Principal Scientist Physical Sciences Inc. Salem, New Hampshire
Biopharmaceutical manufacturing is constrained by its reliance on offline metabolic measurements, limiting real-time control and optimization. While in-line and at-line PAT probes monitor extracellular parameters, detailed cellular-level data remain dependent on delayed offline analysis. To address this gap, Physical Sciences Inc. (PSI) developed an in-line cytometry PAT that provides real-time, continuous single-cell measurements of viable cell count, morphology, metabolic shifts, and physiological state. This technology combines light scattering and fluorescence spectroscopy of endogenous intracellular fluorophores for rapid, multi-parameter analysis. In collaboration with the University of Massachusetts Lowell, Northeastern University and Clemson University, PSI demonstrated the value of this in-line PAT instrument through real-time monitoring of FAD/NADH redox ratio in diverse bioreactor processes, including yeast metabolism, iPSC aggregates, HEK293 cultures for viral vector production, and CHO cell cultures for bioprocessing. This technology enables real-time redox data to optimize cultures, improving transfection efficiency and guiding the culture towards a desired metabolic state.
Learning Objectives:
Discuss how real-time single-cell monitoring can improve biomanufacturing efficiency and control
Discuss how real-time redox data can enhance transfection efficiency and guide cultures toward desired metabolic states
Demonstrate real-time monitoring of metabolic shifts in bioreactor cultures to enhance bioprocess efficiency and improve product quality
Test the technology in yeast, iPSC aggregate, HEK293, and CHO cell cultures
Explore the broader potential for real-time PAT tools in advancing biopharmaceutical and industrial biotechnology applications